Wednesday, April 20, 2016

CardioBrief: Company Betting Big on Genetic Strategy to Resurrect CETP Inhibitor

(MedPage Today) -- But skeptics think CETP inhibitors are a dead end
via CardioBrief: Company Betting Big on Genetic Strategy to Resurrect CETP Inhibitor
by

No comments:

Post a Comment